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Abstract 
Rationale: Although not fully understood, the phenotypic transition of vascular smooth muscle 
cells exhibits at the early onset of the pathology of aortic aneurysms. Exploring the key regulators 
that are responsible for maintaining the contractile phenotype of VSMCs may confer vascular 
homeostasis and prevent aneurysmal disease. X-box binding protein 1, which exists in a 
transcriptionally inactive unspliced form (XBP1u) and a spliced active form (XBP1s), is a key 
component in response to endoplasmic reticular (ER) stress. Compared to XBP1s, little is known 
about the role of XBP1u in vascular homeostasis and disease.  
Objective: We aim to investigate the role of XBP1u in VSMC phenotypic switching and the 
pathogenesis of aortic aneurysms. 
Methods and Results: XBP1u, but not XBP1s, was markedly repressed in the aorta during the early 
onset of aortic aneurysm in both angiotensin II-infused ApoE-/- and CaPO4-induced C57BL/6J 
murine models, in parallel with a decrease in SMC contractile apparatus proteins. In vivo studies 
revealed that XBP1 deficiency in SMCs caused VSMC dedifferentiation, enhanced vascular 
inflammation and proteolytic activity, and significantly aggravated both thoracic and abdominal 
aortic aneurysms in mice. XBP1 deficiency, but not an inhibition of XBP1 splicing, induced VSMC 
switching from the contractile phenotype to a proinflammatory and proteolytic phenotype. 
Mechanically, in the cytoplasm, XBP1u directly associated with the N-terminus of FoxO4, a 
recognized repressor of VSMC differentiation via the interaction and inhibition of myocardin. 
Blocking the XBP1u-FoxO4 interaction facilitated nuclear translocation of FoxO4, repressed SMC 
marker genes expression, promoted proinflammatory and proteolytic phenotypic transitioning in 
vitro and stimulated aortic aneurysm formation in vivo.  
Conclusions: Our study revealed the pivotal role of the XBP1u-FoxO4-myocardin axis in 
maintaining the VSMC contractile phenotype and providing protection from aortic aneurysm 
formation. 
Key words: XBP1u, VSMC phenotypic switching, aortic aneurysm, FoxO4 
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Non-standard Abbreviations and Acronyms: 
XBP1 X-box binding protein 1 
VSMCs vascular smooth muscle cells 
FoxO Forkhead box protein O 
TA thoracic aorta 
AA abdominal aorta 
SM22α smooth muscle 22 alpha 
ApoE apolipoprotein E 
XBP1SMKO smooth muscle cell-specific XBP1 knockout 
AngII angiotension II 
siRNA small interfering RNA 
MRTF myocardin-related transcription factor 
DN dominant negative 
Ad adenovirus 
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Introduction 
Aortic aneurysms, including thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm 
(AAA), are life-threatening cardiovascular events that are characterized by a permanent dilatation 
of the aorta and have an extremely high mortality rate upon rupture. TAA and AAA differ in 
anatomic location of aortic dilatation, risk factors, genetic polymorphisms and histological 
characters.1, 2 For example, AAA represents strong positive association with aging, male gender, 
smoking and dyslipidemia.3 TAA is less common, can occur in all age groups, including young 
children, and is often associated with genetic risk factors and Mendelian syndromes affecting the 
connective tissue. Most recent genetic studies show no genetic overlap between AAA and TAA.1 
TAA exhibits strong correlation with genetic polymorphisms such as mutations in fibrillin-1 
(FBN1)4, smooth muscle actin alpha 2 (ACTA2)5, smooth muscle myosin heavy chain 11 (MYH11)6, 
and TGF-β receptor II (TGFBRII)7, etc, whereas GWAS studies identified several susceptible loci 
for AAA including ANRIL, DAB2 interacting protein, and LRP1 (low-density lipoprotein receptor-
related protein 1) etc.8, 9 Moreover, thoracic and abdominal aortas are also structurally different from 
one another and differ in embryology of VSMCs origin.10 The latter has been suggested to possibly 
contribute to the different pathogenesis of TAA and AAA.2 Although recognized as distinct disease 
entities, both TAA and AAA are pathologically characterized by vascular extracellular matrix 
destruction/remodeling and a loss of vascular smooth muscle cell (VSMC) contractile function.11, 12 
Although not fully understood, VSMCs are highly phenotypically plastic, and the loss of the 
contractile phenotype of VSMCs has been recognized as an early event in both thoracic and 
abdominal aortic aneurysms in a variety of animal models and human aneurysmal tissues.13, 14 
However, the molecular linker connecting VSMC phenotypic transition and aortic aneurysm 
remains elusive.  
X-box binding protein 1 (XBP1) is a key transcription factor controlling the ER-stress response 
and is crucial for cell survival under stress conditions.15, 16 There are three pathways in the ER-stress 
response: the PKR-like ER kinase (PERK), activating transcription factor 6 (ATF6), and inositol-
requiring enzyme 1 alpha (IRE1α) pathways. Upon sensing the accumulation of unfolded proteins, 
IRE1α cleaves unspliced XBP1 (XBP1u) mRNA and removes a 26-nt-long intron, resulting in the 
production of a spliced XBP1 (XBP1s).17 XBP1u and XBP1s have an identical N-terminal 
dimerization domain and internal DNA binding domain but differ in their C-termini.17 XBP1s then 
translocates to the nucleus and transcriptionally regulates genes that are involved in protein folding, 
glycosylation, ER-associated degradation (ERAD), autophagy, lipid biogenesis, and insulin 
secretion, among others.18, 19, 16 Compelling evidence has suggested an essential role of XBP1 
splicing in angiogenesis20, endothelial proliferation and apoptosis20, 21 and in VSMCs migration22 
during the disease states of atherosclerosis and post-injury neointima formation. However, little is 
known regarding the physiological function of XBP1u. Previous studies have indicated that XBP1u 
counteracts XBP1s by shuttling between the nucleus and the cytoplasm and sequestering XBP1s for 
proteasomal degradation.23 A recent study has revealed a role for XBP1u in controlling autophagy 
by recruiting FoxO1 to the 20S proteasome.24 Intriguingly, global knockout of XBP1 causes 
embryonic lethality at E13.5 and leads to reduced vessel formation, thus indicating a pivotal role 
for XBP1 in vascular differentiation/development and function.20 Previous research has indicated 
that XBP1u protects endothelial cells from disturbed flow-induced oxidative stress through 
interaction with histone deacetylase 3 in the cytosol.25 In the current study, we sought to clarify 
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whether XBP1u is also involved in VSMC homeostasis and therefore modulates aortic aneurysm 
formation.  
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The data that support the findings of this study are available from the corresponding author upon 
reasonable request. 
Materials and Methods 
AngII-Induced Aortic Aneurysm in ApoE-/- Mice  
Sixteen-week-old XBP1WTApoE-/- and XBP1SMKOApoE-/- male mice were infused with AngII 
(1000 ng/kg/min, Sigma Aldrich Inc) via subcutaneous osmotic minipumps (Model 2004, ALZA 
Scientific Products) as described previously.26, 27 Systolic blood pressure was measured before and 
after AngII-infusion in conscious mice using the noninvasive tail-cuff BP-2000 system (Visitech 
Systems Inc., NC, USA). Aortic diameters were obtained by in vivo measurements using the Vevo 
770 ultrasound system (Visualsonics, Toronto, Canada). In addition to in vivo measurements, aortas 
from saline- or AngII-infused mice were dissected following sacrifice and perfusion with 4% 
paraformaldehyde to measure the aortic diameters ex vivo. Aortic aneurysm in this model is mainly 
localized to the suprarenal abdominal aorta (distal to the renal arteries), followed by the thoracic 
aorta (ascending aorta and descending aorta) and defined as a localized dilation of aorta greater than 
50% of its adjacent intact portion of aorta.28, 29 Pathological insights include elastin fragmentation, 
inflammatory cells infiltration particularly in the adventitia, and plasma inflammatory cytokines 
increase.11, 12 
 
Luciferase Reporter Assays 
HEK293A, COS-7 cells or human VSMCs (T/G HA VSMC) were transiently co-transfected 
with luciferase reporter and β-galactosidase plasmids using Jet-PEI reagent according to the 
manufacturer’s protocol. One day later, transfected cells were harvested for luciferase activity 
measurement using a luciferase assay kit (Promega, Madison, WI, USA) and β-galactosidase 
activity detection using the OPNG reaction (Promega, Madison, WI, USA). The transcriptional 
activity was presented as the ratio of luciferase activity to respective β-galactosidase activity. 
 
Recombinant Adenovirus Construction and Infection in Mice 
A murine FoxO4 aa 1-89 dominant negative fragment (FoxO4-DN) was subcloned into an 
adenovirus vector pDC316-mCMV-EGFP. Subsequently, the recombinant adenovirus plasmids 
pDC316-mCMV-FoxO4-DN-EGFP were co-transfected with pAV.Des1d vector into HEK293A 
cells to yield the final expression clone Ad-FoxO4-EGFP. Ad-FoxO4-EGFP was amplified by 
infecting HEK293A cells and purified by PD-10 Sephadex precipitation. An adenovirus vector 
carrying green fluorescence protein (Ad-EGFP) was applied as negative control. For in vivo studies, 
1×109 pfu of adenovirus dissolved in 30% pluronic gel solution were perivascularly delivered to the 
suprarenal aortas as described previously.30 The EGFP fluorescence signal was monitored by 
confocal laser scanning microscopy to demonstrate the infection of adenovirus to the medians of 
the aortas. 
 
Statistical Analysis 
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All data are expressed as the mean ± standard error of the mean (SEM). Statistical analysis was 
performed using GraphPad prism 6.0 software (GraphPad Software, San Diego, CA, USA). For 
statistical comparisons, whether data were normally distributed was first evaluated. Then, a check 
was made for similar variances among normally distributed data, followed by Student’s t-test for 
two-group comparisons and ANOVA for comparisons if evaluations of similar variances were 
passed. Non-parametric tests were used where data were not normally distributed. In all cases, 
statistical significance was concluded where the two-tailed probability was less than 0.05. The 
unpaired two-tailed Student’s t-test was applied to compare the leukocyte infiltration, macrophage 
infiltration and cytokines in plasma between XBP1WTApoE-/- and XBP1SMKOApoE-/- mice after 
AngII infusion. The Chi-square test was used to compare the incidence of AAA and the percentage 
of phenotype transition SMCs after XBP1 knockdown or overexpression. Kaplan-Meier survival 
curve was used to analyze the survival percentage of saline- or AngII-infused mice. Nonparametric 
Kruskal-Wallis test with a Dunn’s post-hoc test was applied for comparison of the elastin 
degradation grade between XBP1WTApoE-/- and XBP1SMKOApoe-/- mice after saline or AngII 
infusion. The Paired t-test (two-tailed) was performed for the relative gene-silencing efficiencies of 
the short interfering RNA (siRNA) on XBP1, IRE1α and FoxO4. One-way ANOVA followed by 
Student-Newman-Keuls test for post hoc comparison was applied for the effects of FBS, TGF-β or 
AngII on XBP1 expression, XBP1 siRNA or XBP1 plasmid on SMC differentiation markers and 
transcription factor expression, as well as luciferase activity. Two-way ANOVA followed by the 
Bonferroni test was applied for comparisons of the expression of XBP1, SMC differentiation 
markers and ER-stress markers (GRP78, ATF-6 and p-eIF2α) in the aorta between aneurysmal and 
nonaneurysmal tissues and the aortic diameter between XBP1WTApoE-/- and XBP1SMKOApoe-/- mice 
after saline or AngII infusion, as well as the effect of XBP and IRE1α silencing on MCP-1 and IL-
6 expression and secretion, MMP-2 and MMP-9 expression, and macrophage migration in the 
absence or presence of AngII. 
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Results 
Unspliced XBP1 Reduction Correlates with VSMC Dedifferentiation During 
Early Stage of Aortic Aneurysm Formation  
Systemic infusion of angiotensin II (AngII) via osmotic mini-pumps into ApoE-/- mice for 28 
days has been repeatedly demonstrated to cause aneurysmal pathology in both thoracic and 
abdominal aortas (Online Figure IA-C and Online Table I)26, 31, 12. Therefore, we first compared the 
aortic expression levels of spliced and unspliced XBP1 as well as contractile apparatus proteins at 
early stages (3 and 7 days) in AngII-infused ApoE-/- mice. As expected, VSMC-specific smooth 
muscle α-actin (SMA), calponin and SM22α were significantly decreased as early as 3 days post 
infusion; the reduction persisted through 7 days (Figure 1A). Intriguingly, the protein level of 
XBP1u but not XBP1s was similarly reduced with the contractile proteins in both thoracic 
(including ascending and descending aortas) and abdominal aortas (Figure 1A). To further confirm 
these observations, we used another CaPO4-induced AAA model in C57BL/6J mice (Online Figure 
ID-E). Similarly, XBP1u but not XBP1s was repressed in the abdominal aorta during different stages 
of aneurysm formation (3, 5 and 7 days), which is consistent with VSMC dedifferentiation (Online 
Figure IF). Immunohistochemical analysis further confirmed great reductions of XBP1u and 
VSMC-specific SM22α in the medium tunica of both thoracic (including ascending and descending 
aortas) and abdominal aortic aneurysmal vessel wall in 7-day consecutively AngII-infused ApoE-/- 
mice (Figure 1B), whereas no positive staining was detected by the species-matched IgG (data not 
shown). To determine the cellular localization of XBP1u, confocal fluorescence microscopy was 
performed on normal aortic tissue. XBP1u colocalized primarily in the medial SMCs (Figure 1C). 
Of interest, 10% FBS, which causes VSMCs dedifferentiation, significantly inhibited, whereas 
TGF-β (5 ng/ml) stimulation, which causes VSMCs differentiation, greatly upregulated, XBP1u 
expression in VSMCs (Online Figure IG). Taken together, XBP1u reduction may be involved in the 
phenotypic transition of VSMCs during the pathogenesis of aortic aneurysm. 
In addition, to assess whether ER-stress response is activated at early stage of aortic aneurysms 
formation, the expression of ER-stress molecules including GRP78, ATF6, p-eIF2α and XBP1s was 
detected by western blot (Online Figure IF, H-I and Figure 1A). Consistent with previous studies 32, 
33, GRP78 and p-eIF2α were increased and total ATF-6 was reduced in both AngII and CaPO4 
induced aneurysmal mice (Online Figure IH-I). In contrast, XBP1s was not altered whereas XBP1u 
was repressed at early stage of aneurysmal aortas (Figure 1A and Online Figure IF). Therefore, 
XBP1u reduction but not XBP1s-mediated ER-stress at early stage may be involved in aneurysm 
formation. 
To ask why XBP1u was repressed during aortic aneurysms development, we further evaluated 
the regulatory mechanism of XBP1u. Firstly, real-time PCR results indicated that XBP1u mRNA 
was significantly decreased in AngII-infused thoracic and abdominal aortas (Online Figure IIA). As 
well, both XBP1u mRNA and protein levels were greatly downregulated in response to AngII in 
vitro (Online Figure IIB-C). Next, we found AngII did not transcriptionally affect XBP1u whereas 
ATF634 did as evidenced by luciferase reporter assay (Online Figure IID). Next, we applied 
actinomycin D (ActD) to test whether XBP1u was post-transcriptionally regulated by inhibition de 
novo synthesis of mRNA in VSMCs. Intriguingly, the half-life of XBP1u mRNA was markedly 
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reduced in response to AngII (t1/2 from 90.3 min to 51.9 min) (Online Figure IIE), indicating that 
AngII may regulate XBP1u expression via destabilizing mRNA. Moreover, we applied 
cycloheximide (CHX) and MG-132 to inhibit de novo protein synthesis and proteasomal 
degradation respectively. As shown in Online Figure IIF-G, XBP1u protein level was not affected 
by CHX and MG132. Together, destabilization of XBP1u mRNA in VSMCs may account for the 
XBP1u reduction during aortic aneurysm development. 
 
XBP1 Deficiency in VSMCs Causes Smooth Muscle Cell Dedifferentiation and 
Aggravates Aortic Aneurysms in vivo 
Next, we investigated whether XBP1u reduction causes VSMC phenotypic transition and 
aortic aneurysm. At 4 months of age, the contractile apparatus proteins were greatly reduced in both 
thoracic (including ascending and descending aortas) and abdominal aortas in SM22-Cre+/--
XBP1loxp/loxp (XBP1SMKO) mice compared to littermate SM22-Cre--XBP1loxp/loxp (XBP1WT) mice, as 
shown by western blot analysis and immunohistochemical staining (Online Figure IIIA-C), 
suggesting that XBP1 deficiency may facilitate VSMC dedifferentiation. In addition, the aortic rings 
from XBP1SMKO and XBP1WT mice were treated ex vivo in the absence or presence of AngII (1 μM). 
The secretion of the proinflammatory cytokines MCP-1 and IL-6 and the protease activity of MMP-
2 and MMP-9, which have been repeatedly demonstrated to contribute to the pathogenesis of aortic 
aneurysm,35, 36 were significantly elevated in the conditioned media from XBP1SMKO aortic rings 
compared to XBP1WT aortic rings (Online Figure IIID-E), suggesting that XBP1 deficiency may 
facilitate VSMC transition toward an inflammatory and proteolytic phenotype. Thus, the effect of 
XBP1 deficiency in the development of aortic aneurysm was determined by crossing VSMC 
conditional XBP1SMKO with hyperlipidemic ApoE-/- mice. After AngII (1000 ng/kg/min) infusion for 
4 weeks, systolic blood pressure increased similarly in XBP1SMKOApoE-/- and XBP1WTApoE-/- mice, 
but no obvious difference was observed in body weight, plasma lipids or survival rates between the 
groups of mice (Online Table II and Online Figure IVA).These data suggest that the effects of SMC-
derived XBP1 deficiency were independent on arterial hypertension elevated by AngII or plasma 
lipids. In the absence of AngII infusion, no mice developed spontaneous aortic dilations and 
aneurysms (Figure 2A-E). Nevertheless, in the presence of AngII, XBP1SMKOApoE-/- mice exhibited 
a significant increase in maximal aortic diameter compared to XBP1WTApoE-/- mice in the thoracic 
aortas (aortic root, ascending, and descending) by both ultrasound and ex vivo measurements 
(Online Figure IVB and Figure 2B). As well, XBP1 deficiency in VSMCs enhanced the AAA 
formation, and the incidence of abdominal aortic aneurysm at 28 days was markedly increased, from 
55.55% in AngII-infused XBP1WTApoE-/- mice compared to 100% in AngII-infused 
XBP1SMKOApoE-/- mice (P=0.0177) (Figure 2C-E). Furthermore, AngII-infused XBP1SMKOApoE-/- 
mice had significant increases in maximal aortic diameter compared with control mice 
(XBP1SMKOApoE-/- + AngII, 2.50±0.21 mm vs. XBP1WTApoE-/-+ AngII, 1.79±0.22 mm; P=0.0343; 
Figure 2E). Similarly, further elastic Van Gieson (EVG) staining demonstrated dramatically 
increased elastin fragmentation in AngII-infused XBP1-deficient mice in both thoracic (including 
ascending and descending aortas) and abdominal aortas (Online Figure IVC). Moreover, leukocyte 
(CD45+) and macrophage (CD68+) infiltration were dramatically enhanced in XBP1SMKOApoE-/- 
mice infused with AngII compared to AngII-infused XBP1WTApoE-/- mice in the abdominal aorta 
(Online Figure IVD). In parallel, the upregulated proinflammatory cytokines MCP-1 and IL-6 were 
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observed in plasma (Online Figure IVE). Consistently, the aortas from XBP1SMKOApoE-/- mice 
infused with AngII displayed a marked upregulation of MMP-2 and MMP-9 protein expression in 
both thoracic and abdominal aortas (Online Figure IVF). Meanwhile, no positive staining was 
detected by the species-matched IgG (data not shown). To further verify the role of XBP1 deletion 
in the pathogenesis of aortic aneurysm, we used a CaPO4-induced AAA model in XBP1SMKO and 
XBP1WT mice. Consistent with the previous results, VSMC-specific XBP1 deficiency facilitated 
CaPO4-induced abdominal aortic aneurysm formation (Online Figure IVG-H). Taken together, 
XBP1 deficiency in VSMCs causes VSMC dedifferentiation towards a proinflammatory phenotype 
and aggravates aortic aneurysms in vivo. 
 
Unspliced XBP1 Maintains the Contractile Phenotype of VSMCs  
To explore the definitive alteration of VSMCs due to XBP1 deficiency, we isolated primary 
VSMCs from XBP1SMKOand XBP1WT mice. As shown in Figure 3A, the expression of SMA, 
calponin and SM22α were significantly decreased in XBP1-deficient VSMCs from both thoracic 
and abdominal aortas. Further siRNA knockdown of XBP1 in serum-starved differentiated VSMCs 
resulted in morphological changes from a spindle-like contractile phenotype to a polygonal 
synthetic phenotype (Online Figure VA-B). To further clarify whether XBP1u or XBP1s is involved 
in the VSMC phenotypic switching, siRNA targeting IRE1α and the specific IRE1α 
endoribonuclease inhibitor salicylaldehyde37 were used to inhibit XBP1 splicing (Online Figure VC). 
Interestingly, IRE1α silencing or salicyladehyde application in serum-starved VSMCs displayed no 
effect on VSMC dedifferentiation, indicating XBP1u, rather than XBP1s, may contribute to 
maintaining the contractile phenotype of VSMCs (Online Figure VD and Figure 3B). Similar results 
were observed in primary cultured rat VSMCs (Online Figure VE). Moreover, upon AngII (1 μM) 
stimulation, XBP1 silencing greatly induced the expression or secretion of proinflammatory 
cytokines MCP-1, IL-6, TNF-α and IL-1β (Online Figure VF-G, I), upregulated MMP-2 and MMP-
9 mRNA expression (Online Figure VH-I) and enhanced metalloproteinase activity (Online Figure 
VJ) in both aortic smooth muscle cell line and primary cultured VSMC, as well as facilitated 
increased macrophage recruitment towards VSMCs (Online Figure VK). In contrast, inhibiting 
XBP1 splicing did not affect the above changes (Online Figure VF-K). Accordingly, XBP1u but not 
XBP1s overexpressed in primary VSMCs isolated from XBP1SMKO mice or in 10% serum VSMCs 
circumvented the dedifferentiated phenotype due to XBP1 deficiency (Figure 3C and Online Figure 
VL). Together, XBP1u but not XBP1s maintains the VSMC contractile phenotype and homeostasis. 
XBP1u deletion in VSMCs induced a proinflammatory and proteolytic phenotype in VSMCs. 
 
Unspliced XBP1 Modulates VSMC Phenotype via FoxO4 
To address the underlying mechanism by which XBP1u regulates VSMC contractile proteins 
expression, we first investigated whether XBP1u directly upregulated SMC contractile proteins 
transcription with a luciferase reporter assay (Figure 4A). Transfection of myocardin, a potent 
transcriptional activator of SMC marker genes, into COS-7 cells induced a significant increase in 
expression of luciferase reporters controlled by the promoters of SMA and SM22α respectively. In 
contrast, transfection of XBP1u or XBP1s alone did not affect the luciferase reporter activity (Figure 
CIRCRES/2017/311450/R1 
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4A), suggesting that XBP1u does not directly regulate SMC markers at the transcriptional level. 
Second, we hypothesized that XBP1u may affect serum response factor (SRF), a master 
transcriptional factor for SMC contractile marker genes, by binding to the CArG box of SMC 
marker gene promoters.38 As shown by the ChIP assay in Figure 4B, silencing XBP1 did not affect 
the binding activity of SRF to the CArG box of SMA and calponin gene promoters. Moreover, the 
expression levels of a well-recognized transcriptional factor (SRF), coactivators (myocardin and 
myocardin-related transcription factor, MRTF)39, 40 or suppressors (Krüppel-like factor 4, KLF4 and 
Forkhead box O, FoxOs)41, 42 of VMSC markers were not altered at both the mRNA and protein 
levels (Online Figure VIA-B). Next, we investigated whether XBP1 modulates the subcellular 
translocation of SMC transcriptional cofactors, as compelling evidence indicates that cytoplasm-
nuclear redistribution of SMC cofactors greatly affects the transcriptional program for SMC 
differentiation. For example, PI3K/Akt signaling promotes SMC differentiation, at least in part, by 
stimulating nuclear export of FoxO4, thereby releasing myocardin from its inhibitory influence.41 
As shown in immunofluorescence assays, the silencing of XBP1 but not IREα in serum-starved 
contractile VSMCs accelerated the nuclear translocation of FoxO4 (Figure 4C). In contrast, XBP1 
and IREα silencing did not affect the subcellular redistribution of myocardin (Figure 4C), which is 
consistent with constitutive nuclear localization of myocardin.40 Concomitantly, ectopic 
overexpression of XBP1u, but not XBP1s, in serum-rich dedifferentiated VSMCs and primary 
cultured rat VSMCs facilitated FoxO4 shuttling from the nucleus to the cytoplasm in conjunction 
with morphological alteration of VSMCs from the synthetic to the contractile phenotype (Online 
Figure VIC-D). Both in vitro and in vivo analysis further revealed colocalization of XBP1u and 
FoxO4 in the cytoplasm of both primary VSMCs and aortic walls from thoracic and abdominal 
aortas in XBP1WT mice, whereas there was a nuclear localization of FoxO4 in XBP1SMKO mice 
(Online Figure VIE-F). To further assess whether XBP1u modulates VSMC differentiation by 
interfering with FoxO4, we performed a luciferase reporter assay. In accordance with previous 
reports, FoxO4 represses myocardin-induced transactivation of CArG-dependent SMA-luc and 
SM22α-luc (Figure 4D). This effect could be effectively circumvented by XBP1u but not XBP1s 
(Figure 4D), suggesting that XBP1u may counteract FoxO4 activity. Accordingly, XBP1 silencing-
induced VSMC dedifferentiation was abolished by additional FoxO4 knockdown (Online Figure 
VIG-H), thus reinforcing the idea that XBP1u maintains the contractile phenotype of VSMCs by 
negatively regulating VSMC marker repressor FoxO4.  
 
Unspliced XBP1 Directly Interacts with FoxO4 
Next, we investigated whether XBP1u directly interacts with FoxO4 and therefore affects its 
subcellular localization. Upon serum stimulation, FoxO4 was mostly retained in the nucleus, 
whereas XBP1u was most abundantly expressed in the cytoplasm (Figure 5A). With serum 
starvation, FoxO4 was enriched in the cytoplasm and colocalized with XBP1u (Figure 5A). Next, 
we tested whether endogenous XBP1u interacts with myocardin and FoxO4 by co-
immunoprecipitation assays in differentiated VSMCs. As shown in Figure 5B, XBP1u specifically 
co-immunoprecipitated FoxO4 in differentiated VSMCs, and vice versa. In contrast, there was no 
direct interaction between XBP1u and myocardin, neither between XBP1u and FoxO4 in 
dedifferentiated SMCs (Online Figure VIIA-B). Meanwhile, we confirmed the interaction of XBP1u 
and FoxO4 in primary aortic SMCs isolated from XBP1WT mice, but not in XBP1 deficiency SMCs 
CIRCRES/2017/311450/R1 
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(Online Figure VIIC). Since XBP1u and XBP1s share the same N-terminal domain, we then tested 
whether spliced XBP1 interacts with FoxO4 in SMCs. Interestingly, the interaction of XBP1s with 
FoxO4 was not observed in differentiated SMCs (Figure 5C). Furthermore, a direct interaction was 
further confirmed by co-transfection of HEK293A cells with His-FoxO4 and Flag-XBP1u plasmids 
prior to co-immunoprecipitation. The anti-Flag antibody specifically immunoprecipitated His-
tagged FoxO4 with XBP1u, whereas control IgG did not (Figure 5D), suggesting a direct association 
between XBP1u and FoxO4. Next, we tried to map the precise binding domain between XBP1u and 
FoxO4 by pull-down assays. GST-fused full-length, N-terminus (aa 1-101) and C-terminus (aa 89-
261) constructs of XBP1u were incubated with purified MBP-FoxO4 protein in vitro. As shown in 
Figure 5E, both the full-length and N-terminus XBP1u constructs efficiently immuno-interacted 
with FoxO4, whereas the C-terminus XBP1u construct did not bind. In addition, we performed 
MBP-pulldown assays to determine the binding domain of FoxO4 with XBP1u. As shown in Figure 
5F, the full-length and N-terminus of FoxO4 (aa 1-89), but not other domains, were required for the 
interaction with XBP1u. Together, our data provide the direct evidence that XBP1u directly 
associates with FoxO4 in contractile SMCs.  
 
XBP1u-FoxO4 Cytoplasmic Association Prevents FoxO4 Nuclear Translocation 
and Myocardin Repression in VSMCs 
As FoxO4 negatively regulates myocardin activity and represses SMC contractile marker genes 
transcription41, we hypothesized that an association between XBP1u and FoxO4 may interfere with 
the FoxO4-myocardin interaction and the subsequent release of myocardin coactivator activity. To 
address this issue, we carried out co-immunoprecipitation assays in HEK293A cells transfected with 
Flag-myocardin and His-FoxO4 in the presence or absence of XBP1u or XBP1s (Figure 6A). Indeed, 
XBP1u but not XBP1s inhibited the interaction between FoxO4 and myocardin (Figure 6A). 
Furthermore, the N-terminus of FoxO4 (aa 1-89) was used as a dominant-negative control (FoxO4-
DN) to block the interaction between FoxO4 and XBP1u (Online Figure VIIIA). As a consequence, 
FoxO4 was translocated to the nucleus of differentiated VSMCs, the interaction between FoxO4 
and myocardin increased and the SMC marker genes were markedly repressed at both the mRNA 
and protein levels (Online Figure VIIIB-C and Figure 6B-C). In parallel, the proinflammatory 
cytokines and MMPs expression levels were significantly upregulated, even in the absence of 
stimulus (Figure 6D). To reinforce the observation in vivo, an adenovirus flanking the dominant-
negative domain (Ad-FoxO4-DN, 1×109 pfu per mouse) was periadventitially applied to the ApoE-
/- mice at the suprarenal abdominal aorta (Online Figure VIIID), and these mice were then exposed 
to AngII infusion for 4 weeks. As shown in Figure 6E-F, Ad-FoxO4-DN-infected mice had 
pronouncedly aggravated AngII-induced abdominal aortic aneurysm (Ad-FoxO4-DN + AngII, 50%, 
n=8 vs. Ad-EGFP + AngII, 100%, n=8, P = 0.021) in vivo without influencing the body weight, 
blood pressure or survival rate of mice (Online Table III and Online Figure VIIIE). Similarly, Ad-
FoxO4-DN-infected aortas displayed enlarged aneurysm diameters, more elastin fragmentation, 
enhanced inflammatory cells infiltration and greater plasma inflammatory cytokines (MCP-1 and 
IL-6) (Figure 6G and Online Figure VIIIF-H), similar to the features of AngII-infused 
XBP1SMKOApoE-/- mice. Taken together, XBP1u and FoxO4 association is essential for maintaining 
VSMC homeostasis and inhibiting aortic aneurysm 
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Discussion 
The role of VSMC homeostasis during aortic aneurysm remains elusive. Herein, we have 
identified an essential role of XBP1u in maintaining the VSMC contractile phenotype and 
suppression of vascular inflammation and proteolytic degradation in vitro and in vivo. Intriguingly, 
our study revealed an XBP1u-FoxO4-myocardin network that regulates the VSMC phenotypic 
transition and vascular homeostasis, which may reflect some commonality in the pathophysiology 
of both AAA and TAA. 
In the current study, we identified unspliced XBP1 as a molecular link between VSMC 
homeostasis and aortic aneurysm formation. Vascular SMCs are highly plastic and susceptible to 
phenotypic switching from a contractile phenotype toward a synthetic, inflammatory, or even 
osteochondrogenic phenotype upon various stimulation.13, 30, 43, 22 The dedifferentiation of VSMCs 
has been repeatedly observed during the early onset of a variety of vascular diseases, including 
Marfan syndrome, abdominal aortic aneurysm and dissection.13, 44-46 Dedifferentiated VSMCs are 
prone to migration47, 22, produce more inflammatory cytokines48, exhibit greater proteolytic 
activity13, 48 than contractile VSMCs and subsequently contribute to vascular remodeling. Thus, it 
is pivotal to uncover the endogenous molecules that maintain the contractile phenotype and 
homeostasis of VSMCs. Previous studies identified contractile proteins (smooth muscle α-actin, 
smooth muscle myosin heavy chain 11),5, 6 membrane receptor (TGF-β receptor II),46 transcriptional 
factor or coactivator (SRF, myocardin),39, 38 signaling molecules (integrin ILK, AKT),49, 50 and ECM 
protein (fibrillin-1)4, 51 that maintain VSMC homeostasis and resist aortic aneurysm and dilation. 
Herein, we revealed that XBP1u-deficient VSMCs lost the contractile phenotype and were 
susceptible to both AngII-induced thoracic and abdominal aortic aneurysm and CaPO4-induced 
abdominal aortic aneurysm. XBP1-deficient or silenced VSMCs expressed fewer contractile 
proteins, higher MMP-2/MMP-9 expression and activity, and increased inflammatory cytokines. 
These observations are in accordance with previous reports of MMP-2/936 and MCP-1/IL-6/IL-152, 
35 functioning in aortic aneurysm. Moreover, the observation of an essential role of XBP1u in 
maintaining the VSMC differentiated state is also consistent with a report that XBP-1 global 
knockout mice exhibit embryonic lethality at E13.5 with reduced vessel formation.20  
Notably, our study excludes the dependence of XBP1-splicing linked ER stress with regards to 
unspliced XBP1 for maintaining VSMC homeostasis and prevention of aortic aneurysm. In general, 
the accumulation and aggregation of misfolded proteins and sustained ER stress responses are 
common features of cardiovascular disorders. Previous studies have reported that ER stress 
molecules including GRP-78, GRP-94, p-eIF2α, ATF6α and XBP1s were elevated in aneurysmal 
areas of human AAA and Ang II-induced ApoE-/- mice.33 A deficiency of CHOP, a mediator of ER 
stress in mice, prevents thoracic aortic aneurysm/dissection (TAAD).53 However, these markers 
were detected mostly at late stage of aneurysmal aorta and there is lack of direct evidence that which 
ER-stress signaling pathways participates in the pathogenesis of aortic aneurysms. In the current 
study, we observed no obvious alteration of XBP1s at the early stages of two different murine 
models of aortic aneurysm (Figure 1A and Online Figure IF), which may due to p-eIF2α-mediated 
inhibition of translation.54 In contrast, XBP1u was markedly decreased with time, in parallel with 
the repression of the smooth muscle contractile apparatus proteins (Figure 1A-B and Online Figure 
IF). Silencing of XBP1, but not an inhibition of XBP1 splicing or IRE1α, facilitates VSMC 
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phenotypic switching towards synthetic and inflammatory phenotypes, showing that XBP1u 
protection of VSMCs overwhelmed XBP1s during the pathogenesis of aortic aneurysm. Of interest, 
VSMC dedifferentiation is also a hallmark of postinjury restenosis in vessels, and a previous study 
using the same SMC-specific XBP1 knockout mice has shown that XBP1 deficiency in VSMCs 
abrogates neointimal lesions of injured vessels.22 This discrepancy may be due to different injuries 
in different animal models. Indeed, the latter has reported that PDGF-BB activated XBP-1 splicing 
via interaction with the PDGF receptor, and therefore XBP1s increased SMC migration and 
contributed to neointima formation22, suggesting a context-dependent role for XBP1u and XBP1s 
in various vascular disease states. 
Another interesting finding of the current study is the novel network of XBP1u-FoxO4-
Myocardin in maintaining VSMC homeostasis (Figure 7). Compelling evidence has indicated that 
myocardin is an essential coactivator of serum response factor (SRF) and is a master regulator of 
VSMC differentiation.55 SRF binds to CArG boxes and transcriptionally activates a variety of 
downstream muscle-specific genes, such as SM22α, ACTA2, MYH11, and several other signaling 
pathways.55 A reduction of myocardin availability for SRF by other myocardin-binding proteins, 
such as FoxO4, leads to decreased expression of VSMC contractile apparatus genes.41, 55 In contrast, 
FoxO4 nuclear export to the cytoplasm leads to the release of myocardin and VSMC 
differentiation.41 In the current study, we unraveled a novel regulatory mechanism of myocardin 
activity and VSMC differentiation. In brief, XBP1u binding to FoxO4 in cytoplasm inhibits FoxO4 
nuclear translocation and association with myocardin in the nucleus. XBP1 deficiency led to the 
nuclear accumulation of FoxO4, repressed myocardin activation, reduced SMC marker gene 
expression and enhanced inflammatory responses in the vessels. Disrupting XBP1u interaction with 
FoxO4 in contractile VSMCs or ApoE-/- aorta mimicked XBP1-deficiency induced VSMC 
phenotypic switching and aneurysm formation, highlighting the importance of XBP1u-FoxO4-
myocardin interactions in maintaining VSMC homeostasis. The XBP1-/- mice recapitulated the 
phenotype of myocardin-/- mice, which die at embryonic day 10.5 due to a lack of VSMC 
differentiation.39 In addition, the enhanced inflammatory response of XBP1SMKOApoE-/- mice in 
response to AngII infusion is also in line with a previous report that myocardin negatively regulates 
VSMC inﬂammatory activation.56 Our data are also in line with a previous study showing that 
FoxO4 promotes SMC dedifferentiation in an animal model of restenosis.41 Of interest, a recent 
study of aging revealed that FoxO4 protects senescent cell viability by maintaining p53 
sequestration in nuclear bodies and disrupting this interaction restores p53's apoptotic role, 
highlighting the importance of manipulation of FoxO4 nuclear-cytoplasm shuttling in the regulation 
of cell functions.57  
Of note, XBP1s and XBP1u share the same N-terminal, which is required for FoxO4 binding.24 
Therefore, XBP1s may also interact with FoxO4. Herein, we observed XBP1u mainly localized in 
cytoplasm whereas FoxO4 shuttled between nuclear and cytoplasm upon VSMCs phenotypic 
transition. We observed enhanced association in the contractile phenotype but decreased interaction 
upon dedifferentiation between XBP1u and FoxO4 in the cytoplasm of VSMCs. Interrupting XBP1u 
and FoxO4 cytoplasmic interaction in contractile VSMCs accelerates the nuclear interaction 
between FoxO4 and myocardin and causes cellular dedifferentiation. In contrast to XBP1u, XBP1s 
predominately localized in the nucleus. Although we did observe XBP1s-FoxO4 interaction in 
dedifferentiated SMCs (Online Figure VIID), we did not find XBP1s-FoxO4 association in 
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contractile VSMCs (Figure 5C). In accordance, XBP1s did not interfere with the interaction between 
FoxO4 and myocardin and did not affect the inhibition of FoxO4 on myocardin-induced 
transactivation. In addition, consistent with other studies, we found that inhibition of XBP1 splicing 
lead to enhanced SMC markers expression22, suggesting opposite effect of XBP1u and XBP1s on 
regulation of VSMCs phenotypic transition. XBP1u, but not XBP1s association with FoxO4 is 
pivotal for maintaining VSMC contractile phenotype and homeostasis. In addition to VSMC 
phenotypic switching, the aggravation of vascular inflammation and extracellular matrix 
degradation in aneurysmal XBP1SMKO mice may involve the direct activation of MMP-9 
transcription by FoxO4 during XBP1 deficiency. Targeting XBP1u-FoxO4 interactions may provide 
a novel strategy for the prevention of aneurysm-related disease. 
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Figure Legends 
Figure 1. Unspliced XBP1 reduction occurs in parallel with VSMC dedifferentiation during 
early stage of aortic aneurysm formation. A, Representative western blot and quantification of 
XBP1 and smooth muscle cell (SMC) contractile proteins in ascending, descending and suprarenal 
abdominal aortas from ApoE-/- mice (16-week-old, male; n=5 mice per group) infused with AngII 
(1000 ng/kg/min) for 0, 3 and 7 days. *P<0.05. Asc, ascending aortas; Des, descending aortas; Abd, 
suprarenal abdominal aortas; SMA, smooth muscle α-actin. NS, no significance. B, Representative 
immunohistochemical staining and quantification of XBP1u and SM22α in ascending, descending 
and suprarenal abdominal aortas from ApoE-/- mice (16-week-old, male) infused with saline or 
AngII (1000 ng/kg/min) for 7 days (n=3 mice per group). Scale bar, 50 μm. *P<0.05. C, 
Representative immunofluorescent staining of XBP1u (green) and SM22α (red) in normal 
ascending and suprarenal abdominal aortas of C57BL/6J mice. Nuclei stained by Hoechst were 
indicated in blue. Scale bar, 10 μm.  
 
Figure 2. XBP1 deficiency in VSMCs aggravates AngII-induced aortic aneurysms in vivo. A-
E, 16-week-old XBP1WTApoE-/- and XBP1SMKOApoE-/- male mice were infused with saline or AngII 
(1000 ng/kg/min) for 28 days. XBP1WTApoE-/- + saline, n=6; XBP1SMKOApoE-/- +saline, n=6; 
XBP1WTApoE-/- + AngII, n=9; XBP1SMKOApoE-/- +AngII, n=10. A, Representative morphology of 
thoracic aortas from saline- or AngII-infused XBP1WTApoE-/- and XBP1SMKOApoE-/- mice. B, 
Quantification of maximal aortic diameters measured ex vivo from saline- or AngII-infused 
XBP1WTApoE-/- and XBP1SMKOApoE-/- mice.*P<0.05. NS, no significance. C, Representative 
morphology of aortas from saline- or AngII-infused XBP1WTApoE-/- and XBP1SMKOApoE-/- mice. D, 
Incidence of abdominal aortic aneurysm and dissection in saline- or AngII-infused XBP1WTApoE-/- 
and XBP1SMKOApoE-/- mice (XBP1WTApoE-/- + saline, n=6; XBP1SMKOApoE-/- +saline, n=6; 
XBP1WTApoE-/- + AngII, n=9; XBP1SMKOApoE-/- +AngII, n=10). *P<0.05 by Chi-square test. E, 
Quantification of maximal suprarenal abdominal aortic diameters from saline- or AngII-infused 
XBP1WTApoE-/- and XBP1SMKOApoE-/- mice. *P<0.05. NS, no significance. 
 
Figure 3. Unspliced XBP1 maintains the contractile phenotype of VSMCs. A, Representative 
western blot and quantification of SMC contractile markers and XBP1 in primary VSMCs isolated 
from thoracic aortas (TA) and abdominal aortas (AA) of XBP1WT and XBP1SMKO mice (8- to 12-
week-old, male). Five aortas were pooled in each sample. The experiments were performed four 
times independently. *P<0.05. NS, no significance. B, Western blot analysis of the expression of 
SMC contractile markers and XBP1 in treated A7r5 cells. The data were presented as means ± SEM 
from 7 independent experiments in duplicate. *P<0.05. NS, no significance. C, Representative 
western blot and quantification of SMC contractile markers and XBP1 in primary VSMCs isolated 
from XBP1SMKO mice (8- to 12-week-old, four aortas were pooled in each sample) after transfection 
of Flag-vector or Flag-XBP1u for 48 h. The experiments were performed four times independently. 
*P<0.05. 
 
Figure 4. Unspliced XBP1 modulates VSMC phenotype via FoxO4. A, Luciferase reporter 
CIRCRES/2017/311450/R1 
 24 / 26 
 
analysis in COS-7 cells. SMA promoter-luc reporter- or SM22α promoter-luc reporter-
overexpressing COS-7 cells were transfected with Flag-myocardin, Flag-XBP1u or Flag-XBP1s 
plasmids. The luciferase activity normalized to β-galactosidase activity was presented as the means 
± SEM from three independent experiments performed in triplicate. *P<0.05. NS, no significance. 
B, Chromatin immunoprecipitation assay of SRF binding to SMA and calponin gene promoters in 
A7r5 cells with or without XBP1 silencing by siRNA transfection. The experiments were performed 
three times independently. NS, no significance. C, Representative immunofluorescent staining of 
myocardin (red, upper panels) and FoxO4 (green, lower panels) in A7r5 cells transfected with 
scramble siRNA, XBP1 siRNA or IRE1α siRNA followed by serum-starvation for 24 h. Scale bar, 
50 μm. Three independent experiments were performed. D, Luciferase reporter analysis in 
HEK293A cells. SMA promoter-luc reporter- or SM22α promoter-luc reporter-overexpressing 
HEK293A cells were transfected with Flag-myocardin, Flag-FoxO4, Flag-XBP1u or Flag-XBP1s 
plasmids. The luciferase activity normalized to β-galactosidase activity was presented as means ± 
SEM from 4 independent experiments performed in duplicate. *P<0.05. NS, no significance. 
 
Figure 5. Unspliced XBP1 directly interacts with FoxO4. A, Representative immunofluorescent 
staining of XBP1u (red) and FoxO4 (green) in A7r5 cells with or without 10% serum. Scale bar, 50 
μm. Three independent experiments were performed. B, Co-immunoprecipitation assay of XBP1u 
and FoxO4 in serum-starved A7r5 cells. Left, A7r5 cells were incubated with an anti-XBP1u or 
control IgG antibodies, followed by protein A/G agarose beads. The FoxO4 was measured by 
western blot analysis. Right, A7r5 cells were incubated with an anti-FoxO4 or control IgG 
antibodies. The XBP1u was analyzed by immunoblotting. The aliquots of whole-cell extracts prior 
to immunoprecipitation were applied as input controls. C, Co-immunoprecipitation assay of XBP1s 
and FoxO4 in serum-starved A7r5 cells. A7r5 cells were incubated with an anti-XBP1s or control 
IgG antibodies, followed by protein A/G agarose beads. The FoxO4 was measured by western blot 
analysis. D, Co-immunoprecipitation assay of XBP1u and FoxO4 in HEK293A cells. HEK293A 
cells, transfected with Flag-XBP1u and His-FoxO4, were incubated with an anti-His antibody or 
control IgG, followed by immunoblotting with anti-Flag antibody. E, Purified GST (negative control) 
or GST-fusion proteins of XBP1u full-length (aa 1-261), N-terminus (aa 1-101) and C-terminus (aa 
89-261) constructs were immobilized on glutathione agarose and incubated with purified MBP-
FOXO4. Trapped proteins were detected by immunoblotting with anti-MBP and anti-GST 
antibodies. The red arrows represent the target band. F, Purified MBP (negative control) or various 
MBP-FOXO4 fusion proteins were immobilized on amylose resin and incubated with purified GST-
XBP1u. Trapped proteins were measured by immunoblotting with anti-GST and anti-MBP 
antibodies. The red arrows represent the target band. 
 
Figure 6. Unspliced XBP1 but not spliced inhibites myocardin interaction with FOXO4. A, 
Co-immunoprecipitation analysis of FoxO4 and myocardin. Flag-Myo (Flag-myocardin) and His-
FOXO4-overexpressing HEK293A cells, transfected with pcDNA3.1, pcDNA3.1-XBP1u or 
pcDNA3.1-XBP1s, were harvested for co-immunoprecipitation with an anti-Flag antibody and 
immunoblotting with an anti-His antibody, sequentially. The quantitative data of his after 
immunoprecipitation with flag antibody were from three independent experiments. *P<0.05. NS, 
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no significance. B, Co-immunoprecipitation analysis of FoxO4 and myocardin in serum-starved rat 
primary VSMCs infected with Ad-FoxO4-DN or Ad-EGFP. C, Western blot analysis of SMC 
contractile markers in serum-starved A7r5 cells transfected with Flag-vector or Flag-FoxO4-DN. 
Five independent experiments were performed in duplicate. *P<0.05. D, Quantitative real-time PCR 
analysis of mRNA levels of inflammatory cytokines and MMP-9 in serum-starved A7r5 cells 
transfected with Flag-vector or Flag-FoxO4-DN. The data were expressed as the means ± SEM from 
5 independent experiments performed in duplicate. *P<0.05. E-G, 16-week-old ApoE-/- mice were 
infected periadventitially with adenovirus Ad-EGFP (n=8) or Ad-FoxO4-DN (n=8) in the suprarenal 
abdominal aortas. After 3 days, the mice were infused with AngII (1000 ng/kg/min) for 4 weeks. E, 
Representative morphology of AAA in ApoE-/- mice after 28 days of AngII-infusion. F, Incidence 
of AngII-induced AAA in Ad-EGFP or Ad-FoxO4-DN infected mice. *P<0.05 by Chi-square test. 
G, Quantification of maximal suprarenal abdominal aortic diameters measured ex vivo from AngII-
infused mice. 
 
Figure 7. Schematic illustration of XBP1u-FoxO4-Myocardin in maintaining VSMC 
homeostasis. 
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Novelty and Significance 
What Is Known? 
⚫ The phenotypic switch of vascular smooth muscle cells (VSMCs) proceeds aortic aneurysms. 
⚫ X-box binding protein 1, which exists in a transcriptionally inactive unspliced form (XBP1u) 
and a spliced active form (XBP1s), is a key factor controlling the ER-stress response. 
What New Information Does This Article Contribute? 
⚫ XBP1u is essential to maintain VSMCs homeostasis via ER-stress independent effect. 
⚫ XBP1u deficiency in VSMCs causes both thoracic and abdominal aortic aneurysms in mice.  
⚫ XBP1u-FoxO4-myocardin axis in SMCs plays a pivotal role in maintaining VSMCs phenotype 
and preventing aortic aneurysm formation. 
The molecular link connecting VSMCs phenotypic switching and aortic aneurysm remains elusive. 
Our study revealed that XBP1u is pivotal to maintain the contractile phenotype of VSMCs and 
prevents aortic aneurysm formation. Mechanistically, XBP1u directly binds to cytoplasmic FoxO4 
and prevents FoxO4 nuclear translocation and subsequent repression of myocardin-mediated 
contractile apparatus transcription in VSMCs. Interrupting the XBP1u-FoxO4 interaction 
promotes the proinflammatory and proteolytic phenotype of VSMCs in vitro and stimulates aortic 
aneurysm formation in vivo. Our study highlights the importance of XBP1u-FoxO4-myocardin 
interactions in modulating VSMC phenotypic transition during aortic aneurysm formation. 
 
 
 
 
